Meeder Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-3
| Closed | -$1K | – | 2580 |
|
2021
Q3 | $1K | Sell |
3
-6,396
| -100% | -$2.13M | ﹤0.01% | 2423 |
|
2021
Q2 | $1.18M | Sell |
6,399
-2,699
| -30% | -$496K | 0.05% | 246 |
|
2021
Q1 | $1.39M | Buy |
9,098
+8,031
| +753% | +$1.23M | 0.07% | 216 |
|
2020
Q4 | $167K | Sell |
1,067
-19,734
| -95% | -$3.09M | 0.04% | 333 |
|
2020
Q3 | $2.38M | Sell |
20,801
-135
| -0.6% | -$15.5K | 0.15% | 120 |
|
2020
Q2 | $2.35M | Sell |
20,936
-6,000
| -22% | -$673K | 0.15% | 120 |
|
2020
Q1 | $2.42M | Sell |
26,936
-1,283
| -5% | -$115K | 0.19% | 109 |
|
2019
Q4 | $3.05M | Buy |
28,219
+5,708
| +25% | +$617K | 0.19% | 116 |
|
2019
Q3 | $2.2M | Sell |
22,511
-16,406
| -42% | -$1.61M | 0.15% | 130 |
|
2019
Q2 | $5.1M | Buy |
38,917
+1,174
| +3% | +$154K | 0.36% | 80 |
|
2019
Q1 | $5.1M | Buy |
37,743
+17,771
| +89% | +$2.4M | 0.4% | 73 |
|
2018
Q4 | $1.95M | Buy |
19,972
+3,340
| +20% | +$325K | 0.17% | 114 |
|
2018
Q3 | $2.31M | Buy |
16,632
+748
| +5% | +$104K | 0.17% | 128 |
|
2018
Q2 | $1.97M | Buy |
15,884
+8,216
| +107% | +$1.02M | 0.17% | 130 |
|
2018
Q1 | $855K | Buy |
7,668
+3,072
| +67% | +$343K | 0.08% | 245 |
|
2017
Q4 | $549K | Buy |
4,596
+1,193
| +35% | +$143K | 0.05% | 335 |
|
2017
Q3 | $478K | Buy |
3,403
+2,919
| +603% | +$410K | 0.05% | 367 |
|
2017
Q2 | $59K | Sell |
484
-431
| -47% | -$52.5K | 0.01% | 651 |
|
2017
Q1 | $111K | Buy |
+915
| New | +$111K | 0.01% | 548 |
|
2016
Q4 | – | Sell |
-1,116
| Closed | -$137K | – | 1092 |
|
2016
Q3 | $137K | Sell |
1,116
-5,005
| -82% | -$614K | 0.01% | 576 |
|
2016
Q2 | $715K | Buy |
6,121
+5,306
| +651% | +$620K | 0.07% | 300 |
|
2016
Q1 | $114K | Buy |
+815
| New | +$114K | 0.01% | 678 |
|
2015
Q2 | – | Sell |
-7,335
| Closed | -$1.27M | – | 541 |
|
2015
Q1 | $1.27M | Hold |
7,335
| – | – | 0.14% | 203 |
|
2014
Q4 | $1.36M | Buy |
+7,335
| New | +$1.36M | 0.17% | 157 |
|